Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126346311 | 12634631 | 1 | I | 2013 | 20160727 | 20160809 | 20160809 | EXP | CA-AMGEN-CANSP2016099056 | AMGEN | 75.00 | YR | E | M | Y | 0.00000 | 20160809 | CN | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126346311 | 12634631 | 1 | PS | ENBREL | ETANERCEPT | 1 | Subcutaneous | UNK | 103795 | UNKNOWN FORMULATION | |||||||||
| 126346311 | 12634631 | 2 | SS | METHOTREXATE. | METHOTREXATE | 1 | Unknown | 15 MG, QWK | 0 | 15 | MG | /wk | |||||||
| 126346311 | 12634631 | 3 | SS | ORENCIA | ABATACEPT | 1 | Unknown | UNK | 0 | ||||||||||
| 126346311 | 12634631 | 4 | SS | RITUXAN | RITUXIMAB | 1 | Unknown | UNK | 0 | ||||||||||
| 126346311 | 12634631 | 5 | SS | LEFLUNOMIDE. | LEFLUNOMIDE | 1 | Unknown | 20 MG, QD | 0 | 20 | MG | QD | |||||||
| 126346311 | 12634631 | 6 | SS | GOLD | GOLD | 1 | Unknown | UNK | 0 | INJECTION | |||||||||
| 126346311 | 12634631 | 7 | SS | SULFASALAZINE. | SULFASALAZINE | 1 | Unknown | 1 G, BID | 0 | 1 | G | BID | |||||||
| 126346311 | 12634631 | 8 | SS | ARAVA | LEFLUNOMIDE | 1 | Unknown | UNK | 0 | ||||||||||
| 126346311 | 12634631 | 9 | C | XELJANZ | TOFACITINIB CITRATE | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126346311 | 12634631 | 1 | Rheumatoid arthritis |
| 126346311 | 12634631 | 2 | Rheumatoid arthritis |
| 126346311 | 12634631 | 3 | Product used for unknown indication |
| 126346311 | 12634631 | 4 | Product used for unknown indication |
| 126346311 | 12634631 | 5 | Product used for unknown indication |
| 126346311 | 12634631 | 6 | Product used for unknown indication |
| 126346311 | 12634631 | 7 | Rheumatoid arthritis |
| 126346311 | 12634631 | 8 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126346311 | 12634631 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126346311 | 12634631 | Arthralgia | |
| 126346311 | 12634631 | Arthropathy | |
| 126346311 | 12634631 | Back pain | |
| 126346311 | 12634631 | Drug ineffective | |
| 126346311 | 12634631 | Feeling hot | |
| 126346311 | 12634631 | Hand deformity | |
| 126346311 | 12634631 | Joint range of motion decreased | |
| 126346311 | 12634631 | Liver function test increased | |
| 126346311 | 12634631 | Mobility decreased | |
| 126346311 | 12634631 | Musculoskeletal pain | |
| 126346311 | 12634631 | Osteoarthritis | |
| 126346311 | 12634631 | Pain | |
| 126346311 | 12634631 | Renal failure | |
| 126346311 | 12634631 | Swelling |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126346311 | 12634631 | 2 | 201309 | 201312 | 0 | |
| 126346311 | 12634631 | 5 | 1990 | 201509 | 0 | |
| 126346311 | 12634631 | 6 | 1980 | 0 | ||
| 126346311 | 12634631 | 7 | 201402 | 201405 | 0 | |
| 126346311 | 12634631 | 9 | 20160725 | 0 |